Stay updated on Safety of Ascending Doses in Dravet Syndrome Clinical Trial
Sign up to get notified when there's something new on the Safety of Ascending Doses in Dravet Syndrome Clinical Trial page.

Latest updates to the Safety of Ascending Doses in Dravet Syndrome Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page displays the ClinicalTrials.gov record for the completed STK-001 Dravet syndrome study, including its study design, eligibility criteria, participating locations, and outcome measures, rather than an access-denied error.SummaryDifference56%

- Check15 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check22 days agoChange DetectedA banner announces NIH’s transition to using “Super Intelligence” instead of “Artificial Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check28 days agoChange DetectedThe footer revision identifier changed from v3.7.1 to v3.7.2 on the ClinicalTrials.gov error page.SummaryDifference0.2%

- Check35 days agoChange DetectedThe site footer now displays revision v3.7.1 instead of v3.7.0.SummaryDifference0.2%

- Check56 days agoChange DetectedAccess to the study record is blocked by a 403 Forbidden page, replacing the usual study details with a standard error screen. The visible content now includes a 403 message and site footer, indicating restricted access to this ClinicalTrials.gov record.SummaryDifference18%

Stay in the know with updates to Safety of Ascending Doses in Dravet Syndrome Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Ascending Doses in Dravet Syndrome Clinical Trial page.